AbbVie to acquire UK-based antibody medicines company DJS Antibodies
DJS Antibodies is engaged in the development and commercialisation of antibody medicines that target difficult-to-drug disease-causing proteins, and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Oct 22
DJS Antibodies is engaged in the development and commercialisation of antibody medicines that target difficult-to-drug disease-causing proteins, and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Oct 22
Roche will pay an upfront amount of $25m to HOOKIPA Pharma and potential payments of up to $930m…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
20 Oct 22
The FDA Emergency Use Authorisation decision was based on the findings of the phase 3 Prevent-19 clinical trial…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Oct 22
The proposed acquisition, valued at around $487m plus a contingent value right for up to $610m, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Oct 22
The South Korean company said that the acquisition will extend the commercial footprint of its life sciences division…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
18 Oct 22
Patients subjected to etripamil showed a statistically significant difference in time to conversion to PSVT, compared to placebo,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Oct 22
Under the partnership, both firms will evaluate new treatment approaches by combining beta blockers plus AdAlta’s CXCR4-inhibiting ibodies
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Oct 22
In this connection, the US health regulator has authorised the use of Moderna’s mRNA-1273.222 and a 10-µg booster…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Oct 22
PKU GOLIKE is a phenylalanine-free food, which comprises a blend of amino acids in the form of granules
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Oct 22
The authorised vaccine contains 15-μg of mRNA encoding the spike protein of the wild-type of SARS-CoV-2 and 15-μg…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates